marketcaparena
Search

    IVF

    INVO Fertility, Inc.

    Company overview

    Market capitalization
    $2.37M
    Employees
    33
    Latest publication
    2026-09-29
    About INVO Fertility, Inc.

    INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue2,175,485USD2,015,225USD1,757,094USD1,863,654USD1,637,185USD1,685,966USD1,433,151USD1,836,597USD
    Cost Of Revenue60,147USD5,152USD1,127,749USD2,490,956USD1,279,391USD957,419USD988,465USD861,648USD
    Gross Profit2,115,338USD2,010,073USD629,345USD-627,302USD357,794USD728,547USD444,686USD974,949USD
    Selling General Administrative1,906,750USD2,176,099USD2,128,088USD2,193,049USD2,554,474USD3,476,101USD1,514,593USD2,647,524USD
    Total Operating Expenses3,404,988USD3,601,044USD2,264,829USD2,362,786USD2,820,137USD4,704,354USD1,745,088USD2,877,862USD
    Operating Income-1,289,650USD-1,590,971USD-1,635,484USD-2,990,088USD-2,462,343USD-3,975,807USD-1,300,402USD-1,902,913USD
    Total Other Income Expense Net2,234,544USD-3,948,380USD-1,009,141USD-219,006USD-14,941,243USD298,306USD-301,000USD-342,257USD
    Interest Expense177,227USD180,323USD145,803USD221,325USD311,270USD231,824USD273,629USD369,612USD
    Income Before Tax944,894USD—-2,644,625USD-3,209,094USD-17,403,586USD-3,677,501USD-1,601,403USD-2,245,170USD
    Income Tax Expense56,154USD—12,827USD2,055,853USD—-54,008USD29,259USD—
    Equity Method Income Loss-7,154USD22,168USD12,827USD-19,911USD————
    Net Income888,740USD-5,539,351USD-2,644,625USD-5,284,858USD-17,403,586USD-3,623,493USD-1,630,662USD-2,245,170USD
    Depreciation And Amortization—142,698USD136,741USD169,737USD234,462USD231,810USD230,495USD230,338USD
    Research Development————265,663USD484,780USD0USD0USD
    Net Interest Income————-311,270USD-231,824USD-273,629USD-369,612USD
    Tax Provision————0USD-54,008USD29,259USD0USD
    Net Income From Continuing Ops————-17,403,586USD-3,623,493USD-1,630,662USD-2,245,170USD
    Ebit————-2,462,343USD-3,445,677USD-1,327,774USD-1,875,558USD
    Ebitda————-2,227,881USD-3,213,867USD-1,097,279USD-1,645,220USD
    Reconciled Depreciation————234,462USD231,810USD230,495USD230,338USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue6,841,250USD6,532,000USD3,020,575USD822,196USD4,160,116USD1,037,286USD1,480,213USD494,375USD
    Cost Of Revenue30,571USD3,657,766USD1,934,437USD850,770USD145,052USD88,760USD139,670USD90,367USD
    Gross Profit6,810,679USD2,874,234USD1,086,138USD-28,574USD4,015,064USD948,526USD1,340,543USD404,008USD
    Selling General Administrative7,691,151USD9,078,804USD7,486,454USD9,976,563USD9,015,158USD6,065,066USD——
    Total Operating Expenses14,048,035USD10,999,730USD7,652,399USD10,597,907USD9,231,588USD6,463,492USD3,128,635USD3,038,068USD
    Operating Income-7,237,356USD-8,125,496USD-6,767,155USD-10,626,481USD-5,216,524USD-5,514,966USD-1,788,092USD-2,634,060USD
    Total Other Income Expense Net1,751,010USD-993,255USD-1,239,671USD-263,158USD-1,433,652USD-2,832,314USD-379,019USD-442,031USD
    Interest Expense1,302,074USD1,056,360USD925,909USD59,445USD1,265,359USD2,836,504USD379,019USD442,031USD
    Depreciation And Amortization677,364USD919,603USD200,894USD77,301USD166,082USD34,481USD25,346USD5,190USD
    Income Before Tax-5,486,346USD-9,118,751USD-8,006,826USD-10,889,639USD-6,650,176USD-8,347,280USD-2,167,111USD-3,076,091USD
    Income Tax Expense-150,371USD-22,913USD27,786USD2,872USD4,764USD36USD433USD—
    Equity Method Income Loss31,294USD———————
    Net Income-23,323,054USD-9,095,838USD-8,034,612USD-10,892,511USD-6,654,940USD-8,347,316USD-2,167,544USD-3,076,091USD
    Net Income Applicable To Common Shares-25,130,224USD———————
    Research Development—489,660USD165,945USD544,043USD216,430USD398,426USD——
    Unclassified Operating Expenses—1,431,266USD————3,128,635USD3,038,068USD
    Net Interest Income—-1,056,360USD-925,909USD-59,137USD-1,261,702USD-2,832,314USD——
    Tax Provision—-22,913USD27,786USD2,872USD4,764USD36USD——
    Net Income From Continuing Ops—-9,095,838USD-8,034,612USD-10,892,511USD-6,654,940USD-8,347,316USD——
    Ebit—-8,062,391USD-7,080,917USD-10,830,194USD-5,384,812USD-5,510,776USD-1,788,092USD-2,634,060USD
    Ebitda—-7,142,788USD-6,880,023USD-10,752,893USD-5,218,730USD-5,476,295USD-1,762,746USD-2,628,870USD
    Reconciled Depreciation—919,603USD200,894USD77,301USD166,082USD34,481USD——
    Interest Income——0USD308USD3,657USD4,190USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets25,834,562USD24,656,147USD20,220,124USD18,832,198USD19,319,239USD31,744,110USD46,449,182USD17,019,489USD
    Long Term Investments2,466,810USD2,466,810USD—2,466,810USD2,466,810USD710,855USD740,759USD2,943,826USD
    Total Current Assets4,602,765USD5,734,161USD2,761,503USD1,136,805USD1,399,353USD1,569,122USD1,318,331USD1,957,481USD
    Other Current Assets360,801USD356,764USD—314,952USD395,306USD338,643USD182,290USD987,300USD
    Total Liabilities9,342,984USD9,632,501USD12,995,903USD12,983,476USD16,687,766USD———
    Total Current Liabilities6,519,724USD6,355,838USD10,331,629USD9,244,687USD12,463,211USD18,718,955USD17,926,441USD8,655,458USD
    Other Current Liabilities47,812USD47,812USD—10,500USD10,500USD———
    Other Non Current Liabilities79,688USD79,688USD——————
    Total Stockholder Equity16,491,578USD15,023,646USD7,224,221USD5,848,722USD2,631,473USD3,335,365USD12,747,473USD-23,316USD
    Total Equity Including Noncontrolling Interest16,491,578USD15,023,646USD7,224,221USD5,848,722USD2,631,473USD———
    Short Long Term Debt1,126,687USD————5,378,912USD6,338,071USD1,717,183USD
    Long Term Debt513,386USD————1,086,132USD1,128,713USD1,134,418USD
    Deferred Revenue788,498USD725,493USD—720,407USD834,850USD———
    Net Receivables257,729USD248,387USD217,263USD274,200USD242,255USD173,614USD174,881USD257,051USD
    Inventory251,290USD224,555USD—191,762USD212,611USD216,458USD219,764USD241,539USD
    Property Plant Equipment Net2,984,695USD2,450,851USD1,286,217USD2,502,156USD2,589,126USD2,673,953USD2,750,468USD2,758,890USD
    Goodwill9,251,563USD6,519,232USD—5,878,986USD5,878,986USD———
    Intangible Assets1,359,445USD1,369,795USD—1,430,495USD1,535,845USD17,899,556USD18,103,931USD3,480,306USD
    Accounts Payable1,601,018USD1,668,216USD—2,391,222USD2,226,600USD4,785,477USD5,713,956USD2,655,106USD
    Short Term Debt407,568USD271,793USD208,987USD265,808USD256,620USD5,626,662USD6,577,196USD1,947,912USD
    Common Stock229USD164USD—542USD83USD74USD37USD391USD
    Retained Earnings-96,035,618USD-96,924,358USD-91,369,403USD-93,092,303USD-90,203,241USD-84,873,449USD-67,164,618USD-63,541,125USD
    Total Liab—————28,408,745USD33,701,709USD17,042,805USD
    Other Current Liab—————7,581,486USD5,032,930USD3,490,038USD
    Capital Stock—————30,375,074USD30,375,037USD7,644,295USD
    Good Will—————8,890,624USD23,535,693USD5,878,986USD
    Cash—————840,407USD741,396USD471,591USD
    Cash And Short Term Investments—————840,407USD741,396USD471,591USD
    Current Deferred Revenue—————725,330USD602,359USD562,402USD
    Net Debt—————7,997,123USD9,154,068USD4,863,668USD
    Short Long Term Debt Total—————8,837,530USD9,895,464USD5,335,259USD
    Property Plant Equipment Gross—————3,039,736USD3,086,163USD3,067,151USD
    Common Stock Shares Outstanding—————191,004shares55,136shares44,527shares
    Non Current Assets Total—————30,174,988USD45,130,851USD15,062,008USD
    Non Current Liabilities Total—————9,689,790USD15,775,268USD8,387,347USD
    Net Working Capital—————-17,149,833USD-16,608,110USD-6,697,977USD
    Unclassified Current Liabilities—————-5,378,912USD-6,338,071USD-1,717,183USD
    Unclassified Non Current Liabilities—————8,603,658USD14,646,555USD2,252,929USD
    Unclassified Equity—————57,833,666USD49,537,017USD55,873,123USD
    Non Current Liabilities Other———————5,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets20,220,124USD46,449,182USD18,505,916USD3,709,805USD10,466,380USD10,947,343USD1,795,479USD777,347USD
    Total Current Assets2,761,503USD1,318,331USD1,259,775USD621,087USD6,305,865USD10,542,531USD1,543,440USD731,109USD
    Total Liabilities12,995,903USD———————
    Total Current Liabilities10,331,629USD17,926,441USD8,002,895USD3,338,005USD1,253,004USD2,287,991USD1,501,110USD3,501,570USD
    Total Stockholder Equity7,224,221USD12,747,473USD892,825USD-977,612USD7,310,680USD5,743,106USD-3,713,595USD-2,724,223USD
    Total Equity Including Noncontrolling Interest7,224,221USD———————
    Net Receivables217,263USD174,881USD140,550USD77,149USD50,470USD21,699USD7,558USD225,899USD
    Property Plant Equipment Net1,286,217USD2,750,468USD4,185,476USD1,850,853USD2,538,488USD211,525USD194,938USD34,446USD
    Short Term Debt208,987USD6,577,196USD1,691,494USD922,829USD221,993USD716,390USD21,365USD395,591USD
    Retained Earnings-91,369,403USD-67,164,618USD-57,818,145USD-49,783,533USD-38,891,022USD-32,236,082USD-23,888,766USD-21,721,222USD
    Intangible Assets—18,103,931USD4,093,431USD—132,093USD94,963USD57,101USD11,792USD
    Other Current Assets—182,290USD622,294USD190,201USD282,751USD157,700USD195,910USD249,454USD
    Total Liab—33,701,709USD17,613,320USD4,687,417USD3,155,700USD5,204,237USD5,509,074USD3,501,570USD
    Other Current Liab—5,032,930USD3,572,251USD946,262USD581,689USD527,326USD393,929USD2,515,256USD
    Common Stock—37USD249USD61USD1,193USD964USD15,630USD15,429USD
    Capital Stock—30,375,037USD6,000,249USD61USD1,193USD964USD——
    Good Will—23,535,693USD5,878,986USD0USD————
    Cash—741,396USD232,424USD90,135USD5,684,871USD10,097,760USD1,238,585USD212,243USD
    Cash And Short Term Investments—741,396USD232,424USD90,135USD5,684,871USD10,097,760USD1,238,585USD212,243USD
    Current Deferred Revenue—602,359USD408,769USD119,876USD5,900USD714,286USD714,286USD18,895USD
    Net Debt—9,154,068USD6,069,266USD2,180,157USD-3,561,321USD-9,322,736USD-781,118USD183,348USD
    Short Long Term Debt—6,338,071USD1,509,920USD762,644USD—693,683USD——
    Short Long Term Debt Total—9,895,464USD6,301,690USD2,270,292USD2,123,550USD775,024USD457,467USD395,591USD
    Long Term Debt—1,128,713USD1,253,997USD—————
    Long Term Investments—740,759USD3,088,248USD1,237,865USD1,489,934USD98,084USD——
    Inventory—219,764USD264,507USD263,602USD287,773USD265,372USD101,387USD43,513USD
    Accounts Payable—5,713,956USD2,330,381USD1,349,038USD443,422USD328,927USD371,530USD571,828USD
    Property Plant Equipment Gross—3,086,163USD4,419,069USD2,004,120USD2,616,696USD263,782USD——
    Common Stock Shares Outstanding—42,560shares16,398shares6,943shares6,089shares905,804shares806,002shares795,571shares
    Non Current Assets Total—45,130,851USD17,246,141USD3,088,718USD4,160,515USD404,812USD252,039USD46,238USD
    Non Current Liabilities Total—15,775,268USD9,610,425USD1,349,412USD1,902,696USD2,916,246USD4,007,964USD—
    Net Working Capital—-16,608,110USD-6,743,120USD-2,716,918USD5,052,861USD8,254,540USD——
    Unclassified Current Liabilities—-6,338,071USD-1,509,920USD—————
    Unclassified Non Current Liabilities—14,646,555USD3,356,428USD1,349,412USD1,902,696USD2,916,246USD4,007,964USD—
    Unclassified Equity—49,537,017USD52,710,472USD48,805,799USD46,199,316USD37,977,260USD20,159,541USD18,981,570USD
    Non Current Liabilities Other——5,000,000USD—————
    Non Currrent Assets Other—————240USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation288,271USD
    Other Non Cash Items-172,621USD
    Change To Account Receivables-66,344USD
    Change To Inventory-3,422USD
    Change To Liabilities-488,346USD
    Change In Working Capital-400,395USD
    Operating Cash Flow-3,018,022USD
    Capital Expenditures-19,571USD
    Net Investments-210,000USD
    Unclassified Investing Cash Flow17,355USD
    Investing Cash Flow-212,216USD
    Financing Cash Flow4,885,341USD
    Change In Cash1,655,103USD
    End Cash Flow3,732,945USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation145,573USD142,698USD138,477USD169,737USD234,462USD231,810USD230,495USD230,338USD
    Change To Account Receivables-35,220USD-31,124USD-31,945USD-68,641USD1,267USD82,170USD159USD-80,322USD
    Change To Inventory-4,120USD698USD20,849USD3,847USD3,306USD21,775USD8,527USD16,388USD
    Change To Liabilities-93,945USD-394,401USD——————
    Change In Working Capital140,051USD-540,446USD37,674USD-241,583USD-1,209,093USD1,993,188USD394,009USD-809,548USD
    Operating Cash Flow-1,101,447USD-1,916,575USD——————
    Net Investments0USD-210,000USD——————
    Investing Cash Flow-2,216USD-210,000USD——————
    Financing Cash Flow-67,847USD4,953,188USD——————
    Change In Cash-1,171,510USD2,826,613USD-193,290USD-291,226USD99,011USD269,805USD-471,343USD467,809USD
    End Cash Flow3,732,945USD4,904,455USD——————
    Net Income—-5,539,351USD-2,644,625USD-3,209,094USD-17,403,586USD-3,623,493USD-1,630,662USD-2,245,170USD
    Stock Based Compensation—94,311USD493,348USD680,680USD70,655USD169,367USD106,330USD1,100,106USD
    Unclassified Operating Cash Flow—3,926,213USD——————
    Other Non Cash Items——691,937USD1,563,319USD14,762,028USD611,749USD259,021USD268,617USD
    Total Cash From Operating Activities——-1,776,537USD-1,717,621USD-3,545,534USD-617,379USD-640,807USD-1,455,657USD
    Capital Expenditures——-8,062USD-8,879USD-14,650USD-78,874USD0USD-55,131USD
    Free Cash Flow——-1,784,599USD-1,726,500USD-3,560,184USD-696,253USD-640,807USD-1,510,788USD
    Investments——-8,062USD-15,446USD-14,650USD393,134USD0USD-5,131USD
    Total Cashflows From Investing Activities——-8,062USD-15,446USD-14,650USD393,134USD—-5,131USD
    Net Borrowings——-78,257USD-82,708USD-1,088,795USD494,050USD31,964USD—
    Total Cash From Financing Activities——1,591,309USD1,441,841USD3,659,195USD494,050USD169,464USD1,928,597USD
    Sale Purchase Of Stock——0USD0USD-4,000,000USD—0USD0USD
    Issuance Of Capital Stock——1,650,000USD500,000USD8,747,902USD0USD137,500USD1,171,535USD
    Begin Period Cash Flow——549,181USD840,407USD741,396USD471,591USD942,934USD475,125USD
    End Period Cash Flow——355,891USD549,181USD840,407USD741,396USD471,591USD942,934USD
    Unclassified Financing Cash Flow——1,669,566USD1,024,549USD12,747,902USD———
    Other Cashflows From Investing Activities———-6,569USD———50,000USD
    Other Cashflows From Financing Activities———500,000USD-3,999,912USD—137,500USD1,907,015USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-23,323,054USD-9,095,838USD-8,034,612USD-10,892,511USD-6,654,940USD-8,347,316USD-2,167,544USD-3,076,091USD
    Depreciation677,364USD919,603USD200,894USD77,301USD166,082USD34,481USD25,346USD5,190USD
    Stock Based Compensation178,729USD1,589,646USD1,393,495USD2,224,419USD2,708,189USD1,756,991USD133,537USD2,092,664USD
    Other Non Cash Items-2,135,854USD1,749,433USD1,213,470USD505,429USD1,356,726USD2,626,220USD431,163USD366,126USD
    Unclassified Operating Cash Flow19,141,144USD———————
    Change To Account Receivables-104,155USD-34,331USD-63,401USD-26,679USD-28,771USD-14,141USD218,341USD-139,202USD
    Change To Inventory-5,489USD44,743USD-905USD24,171USD-22,401USD-163,985USD-57,874USD15,366USD
    Change To Liabilities-1,382,698USD———————
    Change In Working Capital-1,552,814USD1,862,756USD471,699USD1,482,043USD-3,605,971USD-845,524USD2,947,578USD-40,860USD
    Operating Cash Flow-7,014,485USD———————
    Capital Expenditures-43,412USD-183,703USD-444,722USD-12,728USD-454,649USD-88,930USD-64,843USD-19,399USD
    Net Investments-2,695,500USD———————
    Unclassified Investing Cash Flow-6,569USD———————
    Investing Cash Flow-2,745,481USD———————
    Financing Cash Flow11,096,412USD———————
    Change In Cash1,336,446USD508,972USD142,289USD-5,594,736USD-4,412,889USD8,859,175USD1,026,342USD186,484USD
    End Cash Flow2,077,842USD———————
    Total Cash From Operating Activities—-2,974,400USD-4,755,054USD-6,603,319USD-6,029,914USD-4,775,148USD1,370,513USD-652,971USD
    Free Cash Flow—-3,158,103USD-5,199,776USD-6,616,047USD-6,484,563USD-4,864,078USD1,305,670USD-672,370USD
    Investments—363,895USD-2,494,879USD-81,217USD-2,153,512USD-187,254USD——
    Total Cashflows From Investing Activities—363,895USD-2,494,879USD-81,217USD-2,153,512USD-187,254USD-114,706USD-19,400USD
    Net Borrowings—409,831USD1,664,848USD800,000USD-250,000USD———
    Total Cash From Financing Activities—3,119,477USD7,392,222USD1,089,800USD3,770,537USD13,821,577USD-229,465USD858,855USD
    Issuance Of Capital Stock—1,809,035USD5,701,948USD289,800USD3,650,697USD11,475,052USD——
    Begin Period Cash Flow—232,424USD90,135USD5,684,871USD10,097,760USD1,238,585USD212,243USD25,759USD
    End Period Cash Flow—741,396USD232,424USD90,135USD5,684,871USD10,097,760USD1,238,585USD212,243USD
    Other Cashflows From Investing Activities—75,590USD—-1,943USD-38,939USD-39,909USD-49,867USD—
    Other Cashflows From Financing Activities—2,544,515USD25,426USD—369,840USD———
    Unclassified Financing Cash Flow—-1,643,904USD———2,346,525USD——
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductInter Segment Revenue12,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductRevenue From External Customers2,016,532USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentFertility Clinic Services1,983,540USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentInvocell Device44,992USDDisclosure
    FY 2025Yearly · 2025-12-31ProductInter Segment Revenue27,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductRevenue From External Customers6,841,250USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentFertility Clinic Services6,721,057USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentInvocell Device147,193USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductClinic Revenue1,722,223USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductProduct34,871USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductClinic Revenue1,832,094USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductProduct31,560USDDisclosure
    Q1 2025Quarterly · 2025-03-31ProductInter Segment Revenue4,500USD0001641172-25-011710
    Q1 2025Quarterly · 2025-03-31ProductRevenue From External Customers1,637,185USD0001641172-25-011710
    Q1 2025Quarterly · 2025-03-31SegmentFertility Clinic Services1,621,553USD0001641172-25-011710
    Q1 2025Quarterly · 2025-03-31SegmentInvocell Device20,132USD0001641172-25-011710
    FY 2024Yearly · 2024-12-31ProductInter Segment Revenue29,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductRevenue From External Customers6,532,000USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentFertility Clinic Services6,450,431USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentInvocell Device110,569USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductClinic Revenue1,537,199USD0001641172-25-011710
    Q1 2024Quarterly · 2024-03-31ProductProduct39,087USD0001641172-25-011710
    Q1 2024Quarterly · 2024-03-31SegmentFertility Clinic Services1,537,199USD0001641172-25-011710
    Q1 2024Quarterly · 2024-03-31SegmentInvocell Device39,087USD0001641172-25-011710
    Q4 2023Quarterly · 2023-12-31ProductClinic Revenue1,362,938USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductProduct18,816USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductClinic Revenue2,862,574USD0001641172-25-006726
    FY 2023Yearly · 2023-12-31ProductProduct158,001USD0001641172-25-006726
    FY 2023Yearly · 2023-12-31SegmentFertility Clinic Services2,862,574USD0001641172-25-006726
    FY 2023Yearly · 2023-12-31SegmentInvocell Device158,001USD0001641172-25-006726
    Q3 2023Quarterly · 2023-09-30ProductClinic Revenue947,891USD0001493152-24-046822
    Q3 2023Quarterly · 2023-09-30ProductProduct27,003USD0001493152-24-046822
    Q2 2023Quarterly · 2023-06-30ProductClinic Revenue254,364USD0001493152-24-031917
    Q2 2023Quarterly · 2023-06-30ProductProduct61,538USD0001493152-24-031917
    FY 2022Yearly · 2022-12-31ProductClinic Revenue614,854USD0001493152-24-014838
    FY 2022Yearly · 2022-12-31ProductProduct207,342USD0001493152-24-014838
    FY 2021Yearly · 2021-12-31ProductClinic Revenue43,745USD0001493152-23-012532
    FY 2021Yearly · 2021-12-31ProductLicense3,571,429USD0001493152-23-012532
    FY 2021Yearly · 2021-12-31ProductProduct544,942USD0001493152-23-012532
    FY 2020Yearly · 2020-12-31ProductLicense Revenue714,286USD0001493152-22-008421
    FY 2020Yearly · 2020-12-31ProductProduct Revenue323,000USD0001493152-22-008421

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.